FDA blasts Eli Lilly for ‘misleading’ Instagram ads

By Becker's Hospital Review - Healthcare News in Becker's Hospital Review, Channels, Featured
January 25, 2022

The FDA sent a letter to Eli Lilly scolding the drugmaker for Instagram ads it posted for its Type 2 diabetes drug Trulicity.

Read the full post on Becker's Hospital Review - Healthcare News

Becker's Hospital Review - Healthcare News